48 research outputs found

    Installation of fuel cell-based cogeneration systems in the commercial and retail sector: Assessment in the framework of the {COMSOS} project

    Get PDF
    This work studies the technical and economic feasibility of the introduction of a SOFC-based cogeneration system to supply non-residential buildings with electricity and heat. The techno-economic evaluation is performed for the hotel and hospital sectors, by introducing real hourly load profiles (electrical and thermal) for the buildings. The analysis considers different countries in terms of energy intensity (and load profiles), cost of energy and regulations/incentives. Results are achieved by comparing the SOFC scenario with a benchmark one where electricity is supplied by the grid and heat by a natural gas fed boiler and evaluating the relative payback time between the two solutions. The analysis showed that, despite the current high investment cost of the SOFC system, in countries such as Germany, Italy and UK (where electricity prices are among the highest in Europe), the option is yet advisable if supported by effective subsidies (already existing for cogeneration systems), and it could offer a competitive alternative to traditional systems, especially in the hospital sector, where the relative payback time is achieved in the 10th year for UK, and in the 14th year for Germany and Italy. A cost reduction scenario has also been analyzed: results show that the SOFC is the best option in most of the locations, both economically and in terms of environmental impact (pollutants emissions reduction)

    Absolut “copper catalyzation perfected”; robust living polymerization of NIPAM : Guinness is good for SET-LRP

    Get PDF
    The controlled polymerization of N-isopropyl acrylamide (NIPAM) is reported in a range of international beers, wine, ciders and spirits utilizing Cu(0)-mediated living radical polymerization (SET-LRP). Highly active Cu(0) is first formed in situ by the rapid disproportionation of [Cu(I)(Me6-Tren)Br] in the commercial water–alcohol mixtures. Rapid, yet highly controlled, radical polymerization follows (Đ values as low as 1.05) despite the numerous chemicals of diverse functionality present in these solvents e.g. alpha acids, sugars, phenols, terpenoids, flavonoids, tannins, metallo-complexes, anethole etc. The results herein demonstrate the robust nature of the aqueous SET-LRP protocol, underlining its ability to operate efficiently in a wide range of complex chemical environments

    Effects of cardioactive drugs on human induced pluripotent stem cell derived long QT syndrome cardiomyocytes

    Get PDF
    Human induced pluripotent stem cells (hiPSC) have enabled a major step forward in pathophysiologic studies of inherited diseases and may also prove to be valuable in in vitro drug testing. Long QT syndrome (LQTS), characterized by prolonged cardiac repolarization and risk of sudden death, may be inherited or result from adverse drug effects. Using a microelectrode array platform, we investigated the effects of six different drugs on the electrophysiological characteristics of human embryonic stem cell-derived cardiomyocytes as well as hiPSC-derived cardiomyocytes from control subjects and from patients with type 1 (LQT1) and type 2 (LQT2) of LQTS. At baseline the repolarization time was significantly longer in LQTS cells compared to controls. Isoprenaline increased the beating rate of all cell lines by 10-73 % but did not show any arrhythmic effects in any cell type. Different QT-interval prolonging drugs caused prolongation of cardiac repolarization by 3-13 % (cisapride), 10-20 % (erythromycin), 8-23 % (sotalol), 16-42 % (quinidine) and 12-27 % (E-4031), but we did not find any systematic differences in sensitivity between the control, LQT1 and LQT2 cell lines. Sotalol, quinidine and E-4031 also caused arrhythmic beats and beating arrests in some cases. In summary, the drug effects on these patient-specific cardiomyocytes appear to recapitulate clinical observations and provide further evidence that these cells can be applied for in vitro drug testing to probe their vulnerability to arrhythmia.Peer reviewe
    corecore